Maddalena Giannella, Daniele Riccucci, Renato Pascale, Elisa Cordero, Nicolas J Mueller, Monica Slavin, Michael Ison
{"title":"Current Practice Patterns and Educational Needs of the ESCMID Study Group for Infections in Compromised Hots.","authors":"Maddalena Giannella, Daniele Riccucci, Renato Pascale, Elisa Cordero, Nicolas J Mueller, Monica Slavin, Michael Ison","doi":"10.1111/tid.70076","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The ESCMID Study Group for Infection in Compromised Hosts (ESGICH) conducted a survey to assess its members' demographics, clinical focus, training pathways, research activities, and educational needs. The primary objective was identifying the current expertise and challenges professionals face in immunocompromised host infectious diseases (ICH-ID) and determining how ESGICH can better support their clinical and research endeavors.</p><p><strong>Methods: </strong>A structured questionnaire was distributed to ESGICH members by email and was posted on X to collect information on work settings, patient populations, training, collaborative networks, research involvement, and educational experiences. The survey also assessed interest in future educational initiatives, including certification programs and targeted training opportunities.</p><p><strong>Results: </strong>Overall, 119 colleagues participated in the survey, with the majority being members of ESGICH, which had approximately 230 participants, yielding a response rate of 52%. Most of the respondents were from Europe and noted significant involvement in ICH-ID clinical care and research. Many respondents provide care for transplant recipients and haemato-oncology patients, with varying levels of institutional support, and often had clinical responsibility beyond the ICH-ID population. Training in ICH-ID is inconsistent, with many participants expressing a need for more structured training pathways. Research engagement was high, though support structures varied. Participants identified key educational gaps and expressed interest in webinars, in-person meetings, and certification programs.</p><p><strong>Conclusion: </strong>The findings highlight the need for ESGICH to enhance educational opportunities, strengthen research networks, and advocate for standardized ICH-ID training. Addressing these gaps will improve professional development and ultimately enhance patient care for ICHs.</p>","PeriodicalId":23318,"journal":{"name":"Transplant Infectious Disease","volume":" ","pages":"e70076"},"PeriodicalIF":2.6000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplant Infectious Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/tid.70076","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The ESCMID Study Group for Infection in Compromised Hosts (ESGICH) conducted a survey to assess its members' demographics, clinical focus, training pathways, research activities, and educational needs. The primary objective was identifying the current expertise and challenges professionals face in immunocompromised host infectious diseases (ICH-ID) and determining how ESGICH can better support their clinical and research endeavors.
Methods: A structured questionnaire was distributed to ESGICH members by email and was posted on X to collect information on work settings, patient populations, training, collaborative networks, research involvement, and educational experiences. The survey also assessed interest in future educational initiatives, including certification programs and targeted training opportunities.
Results: Overall, 119 colleagues participated in the survey, with the majority being members of ESGICH, which had approximately 230 participants, yielding a response rate of 52%. Most of the respondents were from Europe and noted significant involvement in ICH-ID clinical care and research. Many respondents provide care for transplant recipients and haemato-oncology patients, with varying levels of institutional support, and often had clinical responsibility beyond the ICH-ID population. Training in ICH-ID is inconsistent, with many participants expressing a need for more structured training pathways. Research engagement was high, though support structures varied. Participants identified key educational gaps and expressed interest in webinars, in-person meetings, and certification programs.
Conclusion: The findings highlight the need for ESGICH to enhance educational opportunities, strengthen research networks, and advocate for standardized ICH-ID training. Addressing these gaps will improve professional development and ultimately enhance patient care for ICHs.
期刊介绍:
Transplant Infectious Disease has been established as a forum for presenting the most current information on the prevention and treatment of infection complicating organ and bone marrow transplantation. The point of view of the journal is that infection and allograft rejection (or graft-versus-host disease) are closely intertwined, and that advances in one area will have immediate consequences on the other. The interaction of the transplant recipient with potential microbial invaders, the impact of immunosuppressive strategies on this interaction, and the effects of cytokines, growth factors, and chemokines liberated during the course of infections, rejection, or graft-versus-host disease are central to the interests and mission of this journal.
Transplant Infectious Disease is aimed at disseminating the latest information relevant to the infectious disease complications of transplantation to clinicians and scientists involved in bone marrow, kidney, liver, heart, lung, intestinal, and pancreatic transplantation. The infectious disease consequences and concerns regarding innovative transplant strategies, from novel immunosuppressive agents to xenotransplantation, are very much a concern of this journal. In addition, this journal feels a particular responsibility to inform primary care practitioners in the community, who increasingly are sharing the responsibility for the care of these patients, of the special considerations regarding the prevention and treatment of infection in transplant recipients. As exemplified by the international editorial board, articles are sought throughout the world that address both general issues and those of a more restricted geographic import.